KIMBERLY NICHOLS: Open Payments
NPI 1619251626 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 8 payments from 8 companies in 2025. Trend: 2023 $819 · 2024 $592 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $135 |
| Merck Sharp & Dohme LLC | 1 | $129 |
| Iovance Biotherapeutics, Inc. | 1 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $108 |
| AstraZeneca Pharmaceuticals LP | 1 | $107 |
| ABBVIE INC. | 1 | $98 |
| Teleflex LLC | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: REBLOZYL, KEYTRUDA, Amtagvi, Xofigo, DATROWAY, EPKINLY, ARROW, PLUVICTO.
Industry payments across TN — which companies pay providers there.
